Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (711-720 of 1,350) with videos related to

Pageof 135
Sort By:
Drug Development Research|October 12, 2021
Innovative antimicrobial substances based on uracil S-derivativesSvetlana Meshcheryakova, Alina Shumadalova, Ozal Beylerli, et al.
Drug Development Research|October 17, 2019
Discovery of novel halogenated 8-hydroxyquinoline-based anti-MRSA agents: In vitro and QSAR studiesRungrot Cherdtrakulkiat, Apilak Worachartcheewan, Srisurang Tantimavanich, et al.
Drug Development Research|April 26, 2022
Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav-1 signalingJing Chen, Huaming Zhang, Yanbo Yang, et al.
Drug Development Research|October 9, 2019
In vitro and in vivo evaluation of radiolabeled methyl N-[5-(3'-halobenzoyl)-1H-benzimidazol-2-yl]carbamate for cancer radiotherapyZbigniew P Kortylewicz, Don W Coulter, Janina Baranowska-Kortylewicz
Drug Development Research|June 28, 2019
Anti-inflammatory and diuretic effects of the diterpene ent-dihydrotucumanoic acidAngel Josabad Alonso-Castro, Víctor E Arana-Argáez, Martha Alicia Deveze-Alvarez, et al.
Drug Development Research|February 2, 2022
Recent advancement in drug development of nitro(NO<sub>2</sub> )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosisCauê Benito Scarim, Fernando Rogério Pavan
Drug Development Research|September 7, 2018
Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease modelEhraz Anis, Mohd Faraz Zafeer, Fakiha Firdaus, et al.
Drug Development Research|October 5, 2018
Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancerLakshmi Sreedharan Pillai, Saikant Regidi, Shiny Deena Varghese, et al.
Drug Development Research|October 5, 2018
Investigation of the antimicrobial and anticancer activity of aminonaphthoquinonesKevin W Wellington, Natasha I Kolesnikova, Nomgqibelo B P Nyoka, et al.
Drug Development Research|October 13, 2018
Drug resistance in Mycobacterium tuberculosis and targeting the l,d-transpeptidase enzymeKuppan Gokulan, Kottayil I Varughese
Pageof 135

Showing results (711-720 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|October 12, 2021
Innovative antimicrobial substances based on uracil S-derivativesSvetlana Meshcheryakova, Alina Shumadalova, Ozal Beylerli, et al.
Drug Development Research|October 17, 2019
Discovery of novel halogenated 8-hydroxyquinoline-based anti-MRSA agents: In vitro and QSAR studiesRungrot Cherdtrakulkiat, Apilak Worachartcheewan, Srisurang Tantimavanich, et al.
Drug Development Research|April 26, 2022
Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav-1 signalingJing Chen, Huaming Zhang, Yanbo Yang, et al.
Drug Development Research|October 9, 2019
In vitro and in vivo evaluation of radiolabeled methyl N-[5-(3'-halobenzoyl)-1H-benzimidazol-2-yl]carbamate for cancer radiotherapyZbigniew P Kortylewicz, Don W Coulter, Janina Baranowska-Kortylewicz
Drug Development Research|June 28, 2019
Anti-inflammatory and diuretic effects of the diterpene ent-dihydrotucumanoic acidAngel Josabad Alonso-Castro, Víctor E Arana-Argáez, Martha Alicia Deveze-Alvarez, et al.
Drug Development Research|February 2, 2022
Recent advancement in drug development of nitro(NO<sub>2</sub> )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosisCauê Benito Scarim, Fernando Rogério Pavan
Drug Development Research|September 7, 2018
Evaluation of phytomedicinal potential of perillyl alcohol in an in vitro Parkinson's Disease modelEhraz Anis, Mohd Faraz Zafeer, Fakiha Firdaus, et al.
Drug Development Research|October 5, 2018
Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancerLakshmi Sreedharan Pillai, Saikant Regidi, Shiny Deena Varghese, et al.
Drug Development Research|October 5, 2018
Investigation of the antimicrobial and anticancer activity of aminonaphthoquinonesKevin W Wellington, Natasha I Kolesnikova, Nomgqibelo B P Nyoka, et al.
Drug Development Research|October 13, 2018
Drug resistance in Mycobacterium tuberculosis and targeting the l,d-transpeptidase enzymeKuppan Gokulan, Kottayil I Varughese
Pageof 135